Bob Chen, PhD

Bob Chen is Senior Director of Discovery Systems at OmniAb. Dr. Chen leads the development of our xPloration® platform. Dr. Chen previously was the Chief Technology Officer and a co-Founder of xCella Biosciences, an antibody discovery and technology company based in Menlo Park, California, that was built on scientific research from Stanford University and MIT and acquired by Ligand Pharmaceuticals in 2020. Dr. Chen earned a Bachelor’s degree in Chemical Engineering from MIT and a PhD in Bioengineering from Stanford University.